GlaiveOptix
Seed
Nanotechnology to cure blindness
GlaiveOptix is to provide sight to patients with end stage macular diseases utilizing proprietary nanotechnology.
Similar Startups
Ceribell
Series C
Point-of-care EEG for seizure triage and treatment optimization
Xingjuan Chao, PhD ’05, ,
Freenome
Blood test to detect colorectal cancer
Gabriel Otte ’11, ,
Mira
Hormone monitor and supplements
Sylvia Kang, MBA ’13, ,
Epikast
Series B
Engage patients and health providers
Vangelis Vergetis ’01, ,
ModMed
Software for specialty medical practices
Daniel Cane ’98, ,
Moderna
mRNA vaccines
Robert Langer ’70, ,